AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (3.2 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

Development and Head-to-Head Comparison of TwoColloidal gold Based SerologicLateral Flow Assays for SARS-CoV-2 Antibody Tests

Jing Tian1Kan Wang2Yanlei Liu2Hui liang1Xueling Li1Daxiang Cui1,2( )
National Engineering Research Center for Nanotechnology, Shanghai, China
Institute of Nano Biomedicine and Engineering, Shanghai Engineering Research Centre for Intelligent Diagnosis and Treatment Instrument, Department of Instrument Science and Engineering, School of Electronic Information and Electrical Engineering, Shanghai Jiao Tong University, Shanghai, China
Show Author Information

Abstract

To combat the COVID-19 pandemic, serologic lateral flow immunoassays are required to facilitate accurate diagnosis of SARS-CoV-2 infection and confirmation of molecular results. This study evaluated sensitivity of two different designs of colloidal gold serologic tests (antigen based total antibody test and antibody based IgG test) by using residual serum samples from patients who were evaluated for SARS-CoV-2 infection status by polymerase chain reaction (PCR). The results showed 100% specificity for both tests, while when testing of 16 positive patients, the data showed 90% sensitivity for total antibody test and 30% for IgG test. This study demonstrates high diagnostic accuracy for anti-SARS-CoV-2 total antibody tests and will facilitate further development and selection of serological assays.

References

[1]

Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol, 2020, 5(4): 536-544.

[2]

K.G. Andersen, A. Rambaut, W.I. Lipkin, et al., The proximal origin of SARS-CoV-2. Nat Med, 2020, 26: 450-452.

[3]

A. Grifoni, J. Sidney, et al., A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2. Cell Host & Microbe, 2020, 27(4): 671-680.e2.

[4]

A. Wu, Y. Peng, et al., Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host & Microbe, 2020, 27(3): 325-328.

[5]

M. Qiu, Y. Shi, et al., Antibody responses to individual proteins of SARS coronavirus and their neutralization activities Microbes and Infection, 2005, 7: 882-889.

[6]

Q.X. Long, B.Z. Liu, et al., Antibody responses to SARS-CoV-2 in patients with COVID-19. Nature Medicine, 2020, 26: 845-848.

[7]
B. Meyer, et al., Validation of a commercially available SARS-CoV-2 serological immunoassay, Clinical Microbiology and Infection.
[8]
S. E Conklin, et al., Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point of Care Testing. MedRxiv.
[9]

E. Brochot, B. Demey, et al., Comparison of different serological assays for SARS-CoV-2 in real life. Journal of Clinical Virology, 2020, 130: 104569.

Nano Biomedicine and Engineering
Pages 306-310
Cite this article:
Tian J, Wang K, Liu Y, et al. Development and Head-to-Head Comparison of TwoColloidal gold Based SerologicLateral Flow Assays for SARS-CoV-2 Antibody Tests. Nano Biomedicine and Engineering, 2020, 12(4): 306-310. https://doi.org/10.5101/nbe.v12i4.p306-310

610

Views

29

Downloads

3

Crossref

3

Scopus

Altmetrics

Received: 25 August 2020
Accepted: 31 August 2020
Published: 25 October 2020
© Jing Tian, Wang Kan, Liu Yanlei, Liang Hui, Li Xueling, and Cui Daxiang.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Return